IGF-1 LR3 is a long-acting IGF-1 analog with a multi-hour half-life suited to systemic research exposure, while PEG-MGF is a pegylated mechano growth factor variant with a shorter, more localized window of activity tied to the injection site
2011 Oct;211(1):99-106
Kaufman-Janette J, Joseph JH, Kaminer MS, Clark J, Fabi SG, Gold MH, Goldman MP, Katz BE, Peddy K, Schlessinger J, Young VL, Davis M, Hurley D, Liu G, McLane MP, Vijayan S, Bass LS
Adding peptides to conventional treatment foundations Layering benefits: Start with proven conventional treatments (pressure-lowering drops, AREDS2, glucose control)
Uchide, N
The tissue under the tongue is thin and densely supplied with blood vessels, allowing GHK-Cu to absorb directly into systemic circulation bypassing the digestive tract and reaching tissues throughout the entire body, not just one localized area